Linkedin X-twitter
Search

+44 (0)20 7722 1221

[email protected]

VIEW OPPORTUNITIES

SHARE

PAI Pharma acquires Nivagen to expand US sterile injectable manufacturing and hospital offerings

PAI Pharma, backed by Olympus Partners, has acquired Nivagen Pharmaceuticals, adding a new aseptic facility and over 20 ready-to-use injectable products. The move strengthens PAI’s pipeline and aims to address ongoing US hospital drug shortages.
Read the full article.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.